[Antirheumatic drugs and principles for their clinical acceptance]. 1982

A A Krel'

UI MeSH Term Description Entries
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012216 Rheumatic Diseases Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. Rheumatism,Disease, Rheumatic,Diseases, Rheumatic,Rheumatic Disease

Related Publications

A A Krel'
July 1986, Arthritis and rheumatism,
A A Krel'
December 1996, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
A A Krel'
January 1977, Advances in drug research,
A A Krel'
January 1954, Il Farmaco; edizione scientifica,
A A Krel'
November 1993, Clinical pharmacokinetics,
A A Krel'
May 1986, British journal of rheumatology,
A A Krel'
November 1985, British journal of rheumatology,
Copied contents to your clipboard!